Overview

Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure biomarkers in the vitreous of patients undergoing Lucentis or avastin treatment.
Phase:
N/A
Details
Lead Sponsor:
Vitreo-Retinal Associates, Michigan
Collaborator:
Van Andel Research Institute
Treatments:
Bevacizumab
Mitogens
Ranibizumab